US EDT
|
Keynote presentation & Activities
|
07:00 - 8:25
|
Continental Breakfast
|
08:25 - 8:30
|
Greetings and Opening Speech by Chairman
|
Session 1:
DS & DP Particle Engineering
|
08:30 - 08:35 |
Introduction by Moderator.
Moderator: TBD
|
08:35 - 09:25 |
High Supersaturation Driven Three-Dimensional Crystal Growth of an API
Dr. David J. Lamberto, Merck, USA
|
09:25 - 10:15 |
Wish you were sphere: scale-up approaches and polymorph control in spherical crystallization
Dr. Stephanie Kosnik, Boehringer Ingelheim, Germany
|
10:15 - 10:35 |
Coffee/Tea Break |
10:35 - 11:25 |
API particle property control through crystallization, wet milling, ripening, drying, and co-milling
Dr. Guanghui Zhu, Takeda Pharmaceuticals, USA
|
11:25 - 11:55 |
Topical Panel Discussion
Moderator: TBD
|
11:55 - 12:00 |
Closing Remarks by Session Moderator
|
End of Session 1 |
12:00 -13:00 |
Lunch |
Poster Session
|
13:00 – 14:00 |
Poster Session |
Session 2:
Computational/Modeling Support for Crystallization Development
|
14:00 - 14:05 |
Introduction by Moderator.
Moderator: Dr. Yuriy A. Abramov, Porton, USA
|
14:05 - 14:55 |
TBD
Prof. Zoltan Nagy, Purdue University, USA
|
14:55 - 15:45 |
Multi-pronged in silico solid form and crystallization development for ABBV-113: Thermodynamics, Kinetics, and Informatics
Dr. Michelle Liu, Abbvie Inc, USA
|
15:45 - 16:05 |
Coffee/Tea Break |
16:05 - 16:55 |
Computer-aided solid form design: Current challenges, future opportunities
Dr. Susan M. Reutzel-Edens, SuRE Pharma Consulting, LLC, USA
|
16:55 - 17:25 |
Topical Panel Discussion
Moderator: TBD
|
17:25 - 17:30 |
Closing Remarks by Session Moderator
|
End of Session 2 |
17:30 - 17:35 |
Announcements by Chairman on Evening
|
18:30 – 19:30 |
Dinner |
End of Day 2
|